SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses of $1.59M in Q1 FY2026

Q1 FY2026 other income / expenses was $1.59M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.59M+48.3% QoQ
Last fiscal yearDec 2025
$1.58M— YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
1.58M USD
Year-over-year change
—

Other Income / Expenses vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Other Income / Expenses for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$10.45M USD-28.8%—137.3%
OCULOcular Therapeutix, Inc.LTM Mar 2026$8.94M USD-21.4%-18.8%17.2%
RXSTRxSight, Inc.LTM Mar 2026$8.76M USD-15.5%—6.9%
SGPSpyGlass Pharma, Inc. Common StockFY2025$1.58M USD———
SGHTSight Sciences, Inc.LTM Mar 2026-$1.62M USD-403.6%—2.0%
OCSOculis Holding AGLTM Mar 2026-CHF 10.98M CHF+56.5%—2178.2%
STAASTAAR Surgical CompanyLTM Apr 2026-$14.55M USD-327.2%—5.0%
GKOSGlaukos CorporationLTM Jun 2026-$112.34M USD-2575.6%—18.3%
ALCAlcon Inc.LTM Sep 2026-$334.52M USD-69.8%—3.1%
BLCOBausch + Lomb CorporationLTM Jun 2026-$445M USD+6.3%—8.4%
Peer median (excluding SGP) —-28.8%-18.8%8.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.